MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty (MIS GEN II)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00853398|
Recruitment Status : Terminated (The results obtained 1 year after surgery were clearly indicative of the outcome and the investigators decided to terminate follow-up at that point.)
First Posted : March 2, 2009
Last Update Posted : May 23, 2014
Overall study design:
A prospective, randomized, multi-center clinical studies comparing the minimal invasive and the standard surgical total knee replacement technique (control) using the Genesis II total knee system. The study will collect efficacy, safety and socio-economical data over 2 years. An additional 5 years follow-up interval is optional. The objectives (short-term follow-up) of the study are to:
- Assess whether the improvement in Pain and Range of motion per Knee Society scoring system and VAS score.
- Assess whether there are any differences between the surgical techniques as regards complication rate.
- Assess whether the hospital stay and the rehabilitation time (Straight leg raise, Active/passive ROM) of the patients differs between the two techniques.
- Assess the x-ray mechanical alignment between the two techniques.
Attempts will be made to assess whether the collected peri-operative data (including incision length, blood loss, wound appearance, hospital readmissions and operative time) differs between the two surgical techniques.
The primary objectives (mid-term follow-up) of the study are to:
- Improvement in Pain and Function per Knee Society Scoring system
- Number and Extent of Radiographic Lucencies >2mm
- Revision and knee-related adverse events
- Improvement in Quality-of-life via the VAS score
5 investigational sites will participate and enroll a total of approximately 250 patients over a 12 months period. Thus, each site will enroll 50 patients.
|Condition or disease||Intervention/treatment||Phase|
|Osteoarthritis of the Knee||Procedure: surgical technique||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||A Prospective (Non)-Randomized Controlled Multicenter Clinical Study Of the Genesis ii Total Knee System in Minimally Invasive Total Knee Arthroplasty|
|Study Start Date :||October 2004|
|Actual Primary Completion Date :||October 2007|
|Actual Study Completion Date :||December 2007|
|Experimental: Minimal Invasive Surgery,||Procedure: surgical technique|
|Active Comparator: Standard Surgical Technique||Procedure: surgical technique|
- Pain and Range of Motion on the short term as efficacy measurements. Occurence of Adverse Events as safety measurements [ Time Frame: 1 year ]
- Occurence of Adverse Events and Radiolucent lines > 2mm Range of motion on the mid term [ Time Frame: 2 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00853398
|Orthopaedic Department, University Hospital|
|Tübingen, Germany, 72076|